SunCloud Health’sMeasured Outcomes
Though the field we are in has yet to identify a standardized set of outcome measurements we can all use to measure and identify “success”, this has not stopped SCH from measuring and using outcomes that we feel matter to our patients. One of the several tools we use is the OQ-45.2. This patient reported survey measures adult patient progress in therapy, and is designed to be repeatedly measured during the course of treatment, termination and at follow-up. Patient progress is measured along several important dimensions, based on Lambert’s (1983) conceptualization, suggesting that three aspects of the patient’s life be monitored:
- Subjective discomfort (intrapsychic functioning),
- Interpersonal relationships and
- Social role performance.
The OQ maintains high levels of reliability and validity, and SCH has collected thousands of these surveys since we started. Though it is far too early to publish the results of the completed study we are doing, we are pleased to report the following with the hope that if nothing else we show our ongoing commitment to the movement away from pure fee for service and toward some form of value based model where outcomes and cost drive behavior. (SIDE NOTE: If anyone reading this also treats co-occurring substance use, eating disorders, mood disorders and trauma and also uses this measurement, PLEASE LET US KNOW. We would love to share and compare results.)
From admit to discharge, we see an aggregate improvement in our adults as measured by the PHQ-9. Lower scores reflect an improvement.
Video: WHY SUNCLOUD HEALTH? “IT’S OUR PEOPLE”, ELEANOR ANNAN, MD
SunCloud’s biggest asset, “It’s our people”, listen as Eleanor Annan, MD at SunCloud Health explains.
Treatment Outcomes – January 2020
Detailed in this report are the client characteristics and treatment outcomes for over 289 patients who have received services since 2018.
The purpose of this document is to examine the impact of treatment. It can serve as a tool to offer accountability to SunCloud’s clients, staff, and other stakeholders – it offers understanding of whether clients change, by how much, and what might foster that change. It can also be used to celebrate successes and examine areas for professional development and continuous quality improvement.
Overall, the evaluation tells us that SunCloud treatment helps clients reduce their mental health symptoms between admission and discharge. Specifically, on areas of Symptom Distress such as Depression and Anxiety, clients who attend SunCloud experience significant improvements over the course of treatment.
View the Results
Outcome Questionnaire 45.2 (OQ45.2). The OQ45.2 is the treatment outcome indicator for this evaluation. It is a 45-item instrument with three sub-scales: Symptom Distress, which assesses internalizing issues such as depression and anxiety, Interpersonal Relations is a proxy for social relationships, and Social Role assesses compliance with the law and other social behavior. The OQ Total Score and each of the subscales have clinical indicator benchmarks to indicate the point above which can be considered clinically problematic and each has a known ‘reliable change index (RCI)’ for ease in understanding whether therapeutic change is significant. The Total score and all sub-scales have good validity, test-retest reliability (.78-.84), internal consistency (.74-.93).
At admission, average scores on all OQ sub-scales and on the Total score were above the clinical benchmark, indicating clinically problematic functioning. The amount of change on all OQ scores was significant, and exceeded the RCI on Symptom Distress and Total Score.
Table 2. Average OQ Total and Sub-Scale Scores for All SunCloud Clients Pre-to Post-Treatment
To view the complete results of this study and our methodology, the full report can be found here.
Treatment Outcomes – January 2019
The primary metric evaluated is improvement per day as measured in average daily drop in OQ-45.2 scores between admission and discharge. Current patients were omitted and sub-scales were not analyzed. Results are all statistically significant using p<.01.
View the Results
1. The mean OQ 45 improvement per day is statistically significant and equal to 0.444 points/day or 3.11/week. (n=106, p<.001)
2. Patients with higher (worse) scores on intake improve faster.
3. Predicted weekly improvement rates for a particular patient vary widely. As we add more independent variables to the study, we hope to be able to explain this.
4. Patient age does not have any significant relationship with improvement.
5. Controlling for intake score, the longer a patient is in treatment, the worse the improvement rate.
The average time in treatment for patients who have been discharged with two or more tests is about 66 days. The expected rate of improvement after 66 days is still, however, positive and statistically significant.
This report was produced with the much needed help of Brett A. Saranati, Ph.D. Brett is currently a Visiting Professor at Kellogg School of Management at Northwestern University and a Lecturer at Stanford University. Brett’s primary fields of specialization include business statistics, game theory, managerial economics and competitive strategy.
From admit to discharge, we see an aggregate improvement in our adolescents as measured by the PHQ-9. Lower scores reflect an improvement.
Collecting Outcomes
- Level of care patient is coming from previously? Coming from inpatient, higher risk. Coming from outpatient, lower risk.
- How many diagnoses does the patient have? The more they have, the higher risk they are.
- Has the patient been hospitalized for their addiction/mental health issue in the past 5 years?
- Does the patient have a supportive family?
- Are their medical comorbidities at this time as a result of the patient’s condition?
- Any history of overdose or suicide attempt?
SCH is thrilled to announce that it has agreed in principle to enter in to its first “value based” contract with a major payer
This agreement, with one of the country’s largest private insurance companies, holds us accountable for providing certain tasks which we know improve outcomes (aka results) for our patients and their families. It rewards us when our patients do better and in some ways penalizes us when they do not. It requires us to be far more transparent with what we do (and don’t do!), which we embrace passionately and enthusiastically.
Though the program lacks certain characteristics of an ideal “value based program” such as true bundled payments (which forces bundled/coordinated care designed around our patients conditions) and appropriate risk adjustments, it is indeed a step in the right direction! David Newton, Director of Operations for SCH, says of the program, “We are so grateful for this opportunity to be a part of the future of all healthcare, which is finally embracing behavioral health.
Increasing value for our patients by improving outcomes that matter to our patients while at the same time reducing cost is built in to our DNA. When our patients do well, we should do well. And when they don’t do as well, when appropriate we should be held accountable for our provision of care.
This is how the rest of the world operates…Why should healthcare be so different? It shouldn’t be. We are thrilled to be a part of this journey and we look forward to sharing more as we implement the program”.
Dr. Lauren Pace, DO and Psychiatrist on the benefits transparency
Explaining SunCloud’s Integrated Model Why is an integrated treatment model essential to successfully treating patients?
Dr. Kim Dennis, Co-Founder and Medical Director at SunCloud Health, discusses the vital role the integrated model (that she is pioneering at SunCloud Health) plays in the success of treating patients with co-occurring disorders and underlying trauma. How does SunCloud create an authentic culture of patient support?